176 related articles for article (PubMed ID: 16614683)
1. There have been inadequate warnings that erectile dysfunction drugs can cause blindness.
Wolfe SM
MedGenMed; 2005 Dec; 7(4):61. PubMed ID: 16614683
[No Abstract] [Full Text] [Related]
2. How new drugs help treat erectile dysfunction.
Weeks B; Ficorelli CT
Nursing; 2006 Jan; 36(1):18-9. PubMed ID: 16394991
[No Abstract] [Full Text] [Related]
3. Pharmacologic update: treatment of erectile dysfunction in the elderly with phosphodiesterase type 5 inhibitors: cardiovascular implications.
Agarwal P; Sander GE; Giles TD
Am J Geriatr Cardiol; 2004; 13(6):332-5. PubMed ID: 15538074
[No Abstract] [Full Text] [Related]
4. Medication utilization behavior in patients receiving phosphodiesterase type 5 inhibitors for erectile dysfunction.
Mulhall JP; McLaughlin TP; Harnett JP; Scott B; Burhani S; Russell D
J Sex Med; 2005 Nov; 2(6):848-55. PubMed ID: 16422809
[TBL] [Abstract][Full Text] [Related]
5. Patient education series. Erectile dysfunction.
Lewis JH; Rosen R; Goldstein I
Nursing; 2005 Feb; 35(2):64. PubMed ID: 15706284
[No Abstract] [Full Text] [Related]
6. Erectile dysfunction.
Katz A; Katz A
CMAJ; 2010 Mar; 182(4):381-2. PubMed ID: 20142374
[No Abstract] [Full Text] [Related]
7. [Birthday of a "potency pill". Helmut Newton celebrates posthumously likewise].
Keil TU
MMW Fortschr Med; 2004 Jul; 146(29-30):61. PubMed ID: 15540567
[No Abstract] [Full Text] [Related]
8. Are they better than Viagra? Two new drugs for erectile dysfunction work like Viagra and carry similar risks and benefits. Their subtle differences, however, may make a difference for some men.
Harv Health Lett; 2004 Jan; 29(3):3. PubMed ID: 14734283
[No Abstract] [Full Text] [Related]
9. New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction.
Mason RG
J R Soc Promot Health; 2003 Jun; 123(2):79-80. PubMed ID: 12852189
[No Abstract] [Full Text] [Related]
10. Is vardenafil "noninferior" or superior to sildenafil in the management of erectile dysfunction? Revisiting the biochemical, physiological, and clinical evidence.
Traish A; Kim N
J Sex Med; 2008 Jul; 5(7):1762-8; discussion 1768-9. PubMed ID: 18221281
[No Abstract] [Full Text] [Related]
11. The phosphodiesterase inhibitor 'war'.
Wyllie MG
BJU Int; 2003 Apr; 91(6):573-4. PubMed ID: 12656917
[No Abstract] [Full Text] [Related]
12. Editorial comment on the manuscript entitled 'Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction'.
Perimenis P
Expert Opin Pharmacother; 2005 Jan; 6(1):1-2. PubMed ID: 15709877
[No Abstract] [Full Text] [Related]
13. Erectile dysfunction and the drugs to treat it. In many cases, medications are all a man needs to stay sexually active.
Harv Health Lett; 2014 May; 39(7):7. PubMed ID: 25073193
[No Abstract] [Full Text] [Related]
14. Failure of PDE5 inhibitor use: a case of nonresponder? (CME).
Chung E
J Sex Med; 2010 Apr; 7(4 Pt 1):1321-3. PubMed ID: 20492423
[No Abstract] [Full Text] [Related]
15. Comparison of clinical trials with sildenafil, vardenafil and tadalafil in erectile dysfunction.
Doggrell SA
Expert Opin Pharmacother; 2005 Jan; 6(1):75-84. PubMed ID: 15709885
[TBL] [Abstract][Full Text] [Related]
16. Clinical update on phosphodiesterase type-5 inhibitors for erectile dysfunction.
Briganti A; Salonia A; Deho' F; Zanni G; Barbieri L; Rigatti P; Montorsi F
World J Urol; 2005 Dec; 23(6):374-84. PubMed ID: 16273417
[TBL] [Abstract][Full Text] [Related]
17. Successful use of phosphodiesterase type 5 inhibitors to control symptomatic esophageal hypercontractility: a case report.
Agrawal A; Tutuian R; Hila A; Castell DO
Dig Dis Sci; 2005 Nov; 50(11):2059-62. PubMed ID: 16240215
[No Abstract] [Full Text] [Related]
18. Therapy of ED: PDE-5 Inhibitors.
Shabsigh R
Endocrine; 2004; 23(2-3):135-41. PubMed ID: 15146092
[TBL] [Abstract][Full Text] [Related]
19. Phosphodiesterase 5 inhibitors in male sexual dysfunction.
Kuthe A
Curr Opin Urol; 2003 Sep; 13(5):405-10. PubMed ID: 12917517
[TBL] [Abstract][Full Text] [Related]
20. Patterns of treatment with PDE5 inhibitors in the clinical practice in Italy: longitudinal data from the Erectile Dysfunction Observational Study.
Fusco F; Sicuteri R; Rossi A; Kontodimas S; Haro JM; Imbimbo C; Mirone V;
Asian J Androl; 2009 Sep; 11(5):629-37. PubMed ID: 19701217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]